Medesis Pharma SA (ALMDP) — Cash Flow-to-Debt Ratio
Medesis Pharma SA (ALMDP) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2020, meaning its operating cash flow of €185.83K could theoretically repay 0% of its total liabilities (€2.92 Million) in one year. Check total reinvestment intensity of Medesis Pharma SA to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medesis Pharma SA Cash Flow-to-Debt Ratio (2019–2020)
Historical debt coverage capacity for Medesis Pharma SA across 2 annual periods. Also explore how large is Medesis Pharma SA's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Medesis Pharma SA (2019–2020)
Year-by-year debt coverage analysis for Medesis Pharma SA. For market capitalisation and broader financial context, see ALMDP market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2020 | 0.06x | €185.83K | €2.92 Million | ▼ -40.3% |
| 2019 | 0.11x | €333.76K | €3.13 Million | — |